Breaking into new markets is a challenge, and some markets are more difficult to gain access to than others. The obstacles can be many: distances between offices, different time zones, technological complications, language barriers, as well as various legal aspects of new market acquisition can all be difficult hurdles to overcome.
Whenever confronted with new challenges, one of the best approaches in tackling the tasks facing your team is to turn to someone with previous experience with whatever you are trying to do. As a small global company, Viedoc has had to be smart about the decisions made to survive. We have not only survived but are now thriving. We have experienced a lot through the years and want to share that know-how.
Entering the Japanese market over 10 years ago turned out to be tremendously successful for Viedoc as it's become one of the top EDC providers in a market of giants. After the success of entering the Japanese market, further expansion into the Asian market was a natural choice. Using applied knowledge gained in Japan, Viedoc continued with its expansion into China, facing new hurdles and reaching new heights.
We've accomplished a lot over the years, and the upcoming series of blog posts will focus on lessons learned throughout our growth. We will be discussing the measures taken to improve Viedoc over time, as well as what has been accomplished to ensure optimal performance — no matter how new the market is. The outcome is a strong company and a world-class product that is making a difference in clinical trials around the world.
Check back regularly for new posts in our series on how Viedoc has overcome the difficulties faced in breaking into new markets and the challenges that can be imposed when conducting clinical trials there. In the next blog in this series, we'll discuss perhaps one of the most significant complications — cultural differences.
"Viedoc is an easy-to-use platform made even better with great customer service"